Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Adam Khorasanchi"'
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Immune checkpoint inhibitor (ICI) use has been associated with numerous autoimmune side effects, known as immune related adverse events (irAEs). Cutaneous irAEs are common and affect up to 50% of patients treated with ICIs. There have been an increas
Externí odkaz:
https://doaj.org/article/14a7dd95d4aa41bf93eda85bc7a83703
Autor:
Christopher Kwok, Adam Khorasanchi, Sarah P. Psutka, Megan Hinkley, Shawn Dason, Debasish Sundi, Yuanquan Yang, Yajing Yang, Claire Verschraegen, Evan E. Gross, Delaney Orcutt, Ming Yin
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe optimal treatment for metastatic renal cell carcinoma (mRCC) patients who have progressed after both immune checkpoint inhibitor (ICI) and VEGFR tyrosine kinase inhibitor (TKI) remains uncertain. Lenvatinib and everolimus (LE) are frequ
Externí odkaz:
https://doaj.org/article/1a1bbaa7531d4e81bd684d96082c63d7
Publikováno v:
eJHaem, Vol 3, Iss 1, Pp 231-234 (2022)
Abstract Chimeric antigen receptor (CAR) T‐cell therapy represents a new strategy in treating lymphoid malignancies, such as relapsed‐refractory diffuse large B‐cell lymphoma (DLBCL). Several toxicities including cytokine release syndrome (CRS)
Externí odkaz:
https://doaj.org/article/f1b9c29f2abf45759f9c3561874e6a62
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
Malnutrition is common in cancer patients and can occur throughout a patient’s disease course. The contributors to the clinical syndrome of cancer cachexia are often multifactorial, and produced by the cancer and associated pro-inflammatory respons
Externí odkaz:
https://doaj.org/article/5ff51ece867b4a9aa1b2dd314f6c728e
Autor:
Adam Khorasanchi, Zachary Benson, Misty Hall, Nelya Ebadirad, Mohammad H. Gharavi, Patrick Willard, Miranda Chimzar, John McKay, Gary Simmons, Victor Yazbeck
Publikováno v:
Case Reports in Hematology, Vol 2022 (2022)
Primary central nervous system diffuse large B-cell lymphoma (PCNS-DLBCL) is a rare form of non-Hodgkin’s lymphoma, characterized by an aggressive disease course. While CNS relapse is common, systemic relapse is rare with no consensus on optimal tr
Externí odkaz:
https://doaj.org/article/69979001c7f24a5ba2bc0399beb00e22
Publikováno v:
Clinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
Abstract Hemorrhage in patients with hematologic malignancies is often difficult to manage as many of these patients also have coagulopathy and thrombocytopenia of varying severity. Recombinant factor VIIa is a FDA‐approved agent for management of
Externí odkaz:
https://doaj.org/article/8c32758b797d4d20b4dd364c0121569e
Publikováno v:
Gynecologic Oncology Reports, Vol 32, Iss , Pp - (2020)
We present a case report of a patient with uterine primitive neuroectodermal tumor (PNET). The patient underwent surgical management followed by pelvic radiation and intravaginal brachytherapy. Following a stable interval, the patient was found to ha
Externí odkaz:
https://doaj.org/article/8d3a6b4d50194acabdda5dbc23c239ad
Publikováno v:
Kompass Nutrition & Dietetics. 3:30-35
Malnutrition is common in cancer patients and can occur throughout a patient’s disease course. The contributors to the clinical syndrome of cancer cachexia are often multifactorial, and produced by the cancer and associated pro-inflammatory respons
Publikováno v:
eJHaem. 3:231-234
Publikováno v:
Cancers. 14(21)
Cutaneous squamous cell carcinoma (CSCC) is the second most common non-melanoma skin cancer. A majority of patients present with localized disease, but some can present with locally advanced or metastatic disease. Most of these advanced cases occur i